Performance Study of the Invendo C20 Colonoscope System in Colorectal Cancer Screening

NCT01054924 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2010-01-22

No results posted yet for this study

Summary

The purpose of the study is to evaluate efficacy (i.e. reaching the cecum) and safety of the Invendo C20 Colonoscopy System

Conditions

  • Colorectal Cancer Screening

Sponsors & Collaborators

  • Invendo Medical GmbH

    lead INDUSTRY

Principal Investigators

  • Thomas Roesch, Prof. · Universitätsklinikum Hamburg-Eppendorf

  • Nicolas Hoepffner, MD · Centrum Gastroenterologie Bethanien, Frankfurt

  • Douglas K. Rex, Prof. · Indiana University Hospital

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01054924 on ClinicalTrials.gov